14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for OncoMed Pharmaceuticals Stock and on which exchange is it traded?
The symbol for OncoMed Pharmaceuticals is OMED and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell OncoMed Pharmaceuticals Stock?
OncoMed Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy OncoMed Pharmaceuticals Stock?
OncoMed Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy OncoMed Pharmaceuticals Stock.

What's the current price of OncoMed Pharmaceuticals Stock?
As of the end of day on the Sep 17, 2019, the price of an OncoMed Pharmaceuticals (OMED) share was $0.89.

What is the 52-week high and low for OncoMed Pharmaceuticals Stock?
The 52-week high for OncoMed Pharmaceuticals Stock is $3.25 and the 52-week low is $0.547.
Click to get the best stock tips daily for free!

About OncoMed Pharmaceuticals

OncoMed Pharmaceuticals, Inc., a clinical development-stage biopharmaceutical company, discovers and develops novel anti-cancer stem cell (CSC) and immuno-oncology therapeutics. The company’s product candidates and preclinical programs include demcizumab (anti-DLL4, OMP-21M18), a humanized monoclonal antibody, which is in two Phase II clinical trials for non-small cell lung cancer and pancreatic cancer patients; tarextumab (anti-Notch2/3, OMP-59... OMED Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT